ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,866Medicare Part D Prescriptions Filled, Including Refills

Rank: 147 out of 5176

$1.5M Total Retail Price of All Prescriptions

Rank: 108 out of 5176

330 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 330 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 17,371 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 697 687 1 16
METOPROLOL TARTRATE 650 641 2 6
CRESTOR 576 575 3 15
AMLODIPINE BESYLATE 519 500 4 2
SYNTHROID 459 417 5 33
ATORVASTATIN CALCIUM 441 416 6 9
ZETIA 423 417 7 68
SIMVASTATIN 387 372 8 1
ZOLPIDEM TARTRATE 345 340 9 17
PLAVIX 318 310 10 29
METOPROLOL SUCCINATE 317 317 11 11
LIPITOR 311 296 12 51
FUROSEMIDE 257 257 13 8
LOSARTAN POTASSIUM 233 217 14 14
DIOVAN 232 232 15 19
JANUVIA 229 215 16 25
ISOSORBIDE MONONITRATE ER 226 226 17 44
CARVEDILOL 225 220 18 24
TAMSULOSIN HCL 215 207 19 20
LIDODERM 211 207 20 59
CLOPIDOGREL 201 199 21 26
OMEPRAZOLE 193 159 22 3
COUMADIN 192 192 23 112
BENICAR 187 187 24 100
BENICAR HCT 185 185 25 110
HYDROCHLOROTHIAZIDE 180 171 26 10
HYDRALAZINE HCL 180 180 26 73
DEXILANT 166 166 28 118
LOSARTAN-HYDROCHLOROTHIAZIDE 163 152 29 35
RAMIPRIL 161 161 30 50
ADVAIR DISKUS 154 154 31 32
ALENDRONATE SODIUM 148 148 32 18
VYTORIN 148 148 32 152
ALLOPURINOL 147 135 34 41
CREON 147 147 34 111
ENALAPRIL MALEATE 142 128 36 22
ATENOLOL 138 135 37 12
METFORMIN HCL 138 138 37 7
JANUMET 138 122 37 77
ACTONEL 130 125 40 134
DIOVAN HCT 127 119 41 39
BYSTOLIC 121 112 42 96
CLONIDINE HCL 115 113 43 79
GLIMEPIRIDE 115 115 43 37
DIGOXIN 111 111 45 56
ESCITALOPRAM OXALATE 102 102 46 89
LACTULOSE 100 100 47 87
LOVAZA 97 89 48 43
PRANDIN 96 92 49 150
CELEBREX 95 88 50 80
TOPROL XL 94 92 51 227
SPIRIVA 93 75 52 54
LANSOPRAZOLE 92 81 53 113
SOLARAZE 91 90 54 157
PROCTOZONE-HC 88 88 55 171
PROAIR HFA 88 84 55 60
CLOTRIMAZOLE-BETAMETHASONE 86 86 57 94
AVODART 83 83 58 107
FAMOTIDINE 80 80 59 58
NITROSTAT 79 79 60 205
NITROGLYCERIN PATCH 79 79 60 149
LEVOTHYROXINE SODIUM 78 78 62 4
AMMONIUM LACTATE 78 78 62 91
ACARBOSE 75 75 64 223
EXELON 75 75 64 162
ONGLYZA 74 74 66 153
DONEPEZIL HCL 73 73 67 28
ENALAPRIL-HYDROCHLOROTHIAZIDE 72 67 68 212
DILTIAZEM 24HR CD 70 70 69 119
LEXAPRO 69 69 70 193
ACETAMINOPHEN-CODEINE 69 69 S3 70 127
SINGLE USE SWAB 69 69 70 108
RANITIDINE HCL 69 68 70 36
SINGULAIR 67 67 74 62
ALCOHOL SWABS 66 66 75 115
POTASSIUM CHLORIDE 64 64 76 34
CILOSTAZOL 64 64 76 206
PROPRANOLOL HCL 63 63 78 199
MICARDIS 62 62 79 154
PRADAXA 58 58 80 192
GABAPENTIN 58 58 80 21
ULORIC 56 56 82 280
GLIPIZIDE 56 56 82 63
FLUTICASONE PROPIONATE 55 55 84 38
COREG CR 55 55 84 275
MICARDIS HCT 54 54 86 180
CITALOPRAM HBR 53 53 87 31
LISINOPRIL 52 52 88 5
VOLTAREN 52 52 88 97
ACTOS 51 43 90 85
MECLIZINE HCL 51 50 90 81
EXFORGE 51 51 90 126
AMLODIPINE BESYLATE-BENAZEPRIL 50 50 93 55
FINASTERIDE 50 50 93 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.